Lavipharm S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
30,069.00
30,429.00
26,879.00
32,034.00
32,548.00
33,845
Cost of Goods Sold (COGS) incl. D&A
16,880.00
17,535.00
15,633.00
17,478.00
17,345.00
17,045
Gross Income
13,189.00
12,894.00
11,246.00
14,556.00
15,203.00
16,800
SG&A Expense
16,638.00
27,140.00
13,170.00
14,940.00
13,941.00
14,696
EBIT
5,403.00
15,320.00
3,473.00
2,628.00
1,189.00
1,834
Unusual Expense
563.00
10,002.00
437.00
16,901.00
12,324.00
23
Non Operating Income/Expense
1,914.00
2,481.00
3,215.00
1,982.00
1,086.00
2,948
Interest Expense
8,433.00
8,088.00
9,288.00
4,603.00
1,994.00
1,927
Pretax Income
12,120.00
30,911.00
9,970.00
11,680.00
12,892.00
2,861
Income Tax
845.00
2,033.00
514.00
2,806.00
37.00
1,610
Equity in Affiliates
18.00
60.00
174.00
133.00
-
-
Consolidated Net Income
11,257.00
28,818.00
10,658.00
8,741.00
12,929.00
1,251
Net Income
13,066.00
26,085.00
7,074.00
3,660.00
12,925.00
1,249
Net Income After Extraordinaries
13,066.00
26,085.00
7,074.00
3,660.00
12,925.00
1,249
Net Income Available to Common
13,066.00
26,085.00
7,074.00
3,660.00
12,925.00
1,249
EPS (Basic)
0.26
0.51
0.14
0.07
0.25
0.02
Basic Shares Outstanding
51,081.00
51,081.00
51,081.00
51,081.00
51,081.00
51,081
EPS (Diluted)
0.26
0.51
0.14
0.07
0.25
0.02
Diluted Shares Outstanding
51,081.00
51,081.00
51,081.00
51,081.00
51,081.00
51,081
EBITDA
2,640.00
11,194.00
896.00
820.00
3,401.00
3,018
Other Operating Expense
1,954.00
1,074.00
1,549.00
2,244.00
73.00
270
Non-Operating Interest Income
365.00
18.00
13.00
28.00
287.00
29
Minority Interest Expense
1,809.00
2,733.00
3,584.00
5,081.00
4.00
2
About Lavipharm
View Profile
